Abstract

ObjectiveTo compare the effectiveness of sotrovimab (a neutralising monoclonal antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients infected with SARS-CoV-2 in the community and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.
Viyaasan Mahalingasivam ... Jonathan Cockburn
The Lancet regional health. Europe | VOL. 34
Viyaasan Mahalingasivam, et. al.Viyaasan Mahalingasivam ... Jonathan Cockburn
01 Nov 2023
Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging.
Melissa K Andrew ... Shelly Mcneil
PloS one | VOL. 17
Melissa K Andrew, et. al.Melissa K Andrew ... Shelly Mcneil
30 Sep 2022
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis.
Jessica Widdifield ... Simon Chen
The Lancet. Rheumatology | VOL. 4
Jessica Widdifield, et. al.Jessica Widdifield ... Simon Chen
14 Apr 2022
Changing COVID-19 outcomes in patients with rheumatic disease-are we really getting better at this?
Milena A Gianfrancesco ... Philip C Robinson
The Lancet. Rheumatology | VOL. 3
Milena A Gianfrancesco, et. al.Milena A Gianfrancesco ... Philip C Robinson
28 Jan 2021
View more papers

More From: BMJ

Paper Title
Journal
Date
Author
New WHO guidance can support transparent and informed engagement with the private sector
Kent Buse ... Monika Arora
BMJ | VOL. 385
Kent Buse, et. al.Kent Buse ... Monika Arora
29 May 2024
Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders
Matthew Limb
BMJ | VOL. 385
Matthew LimbMatthew Limb
29 May 2024
Sudan: Aid workers describe “bloodbath” in Darfur as hospitals are repeatedly attacked
Elisabeth Mahase
BMJ | VOL. 385
Elisabeth MahaseElisabeth Mahase
29 May 2024
US state classifies mifepristone and misoprostol as dangerous controlled substances
Janice Hopkins Tanne
BMJ | VOL. 385
Janice Hopkins TanneJanice Hopkins Tanne
29 May 2024
View more papers